Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Gabapentin for Reducing Inhalational Anesthetic Consumption
NCT05301205Phase 1Unknown
- Sponsor
- Cairo University
- Start
- Jun 2021
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of gabapentin in intracranial tumor (3 arms), sponsored by Cairo University. Primary endpoint: Sevoflurane consumption at 4 hours. Status: unknown.
02
Drugs
gabapentin
03
Conditions
intracranial tumor
Beyond the preview
Go deeper on NCT05301205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05301205.